In another context, psilocybin, administered post-stroke, improves motor recovery, reduces neuroinflammation, and promotes neuroplasticity by activating the TrkB receptor and increasing levels of BDNF, MAP2, and synaptophysin. The gene discussed is MAP2; the disease is Stroke.